# Evaluate the Distribution and Dynamic Behavior of Nuclide Labeled TH-SC01 Cells in Vivo in Patients With Radiation Proctitis

> **NCT06925607** · PHASE1 · NOT_YET_RECRUITING · sponsor: **Jiangsu Topcel-KH Pharmaceutical Co., Ltd.** · enrollment: 6 (estimated)

## Conditions studied

- Radiation Proctitis

## Interventions

- **DRUG:** Mesenchymal Stem Cells (MSCs)

## Key facts

- **NCT ID:** NCT06925607
- **Lead sponsor:** Jiangsu Topcel-KH Pharmaceutical Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-04
- **Primary completion:** 2026-03
- **Final completion:** 2026-12
- **Target enrollment:** 6 (ESTIMATED)
- **Last updated:** 2025-04-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06925607

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06925607, "Evaluate the Distribution and Dynamic Behavior of Nuclide Labeled TH-SC01 Cells in Vivo in Patients With Radiation Proctitis". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT06925607. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*